Across TCGA pan-cancer cohorts, TULP3 mass-spec protein is linked to patient survival in 4 of 34 cancer types, making it a survival-associated TULP3 data layer compared with 21 for mass-spec protein and 4 for mutation status.
The strongest signal is observed in uterine corpus endometrial carcinoma (UCEC), where higher TULP3 mass-spec protein is associated with worse overall survival. In most high-consensus cancer types, elevated TULP3 expression acts as an unfavorable survival marker, although some lineages such as HNSC show a favorable association.
UCEC, CCRCC, and LUAD are the cancer types where TULP3 mass-spec protein most reproducibly stratifies survival.